146 related articles for article (PubMed ID: 6428229)
1. Biomedical genetics of the inherited metabolic diseases: the GM2-gangliosidoses.
Kolodny EH
Am J Ment Defic; 1984 Mar; 88(5):582-9. PubMed ID: 6428229
[TBL] [Abstract][Full Text] [Related]
2. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
6. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
[TBL] [Abstract][Full Text] [Related]
7. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
[TBL] [Abstract][Full Text] [Related]
8. [Identification of GM2-gangliosidosis using an in vitro loading test].
Akhunov VS; Krasnopol'skaia KD
Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
Pampiglione G; Harden A
Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
[TBL] [Abstract][Full Text] [Related]
10. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
[TBL] [Abstract][Full Text] [Related]
11. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
Akhunov VS; Mirenburg TV; Krasnopolskaya XD
J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
[TBL] [Abstract][Full Text] [Related]
12. Biochemistry and genetics of gangliosidoses.
Sandhoff K; Christomanou H
Hum Genet; 1979; 50(2):107-43. PubMed ID: 116955
[TBL] [Abstract][Full Text] [Related]
13. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis.
Meek D; Wolfe LS; Andermann E; Andermann F
Ann Neurol; 1984 Apr; 15(4):348-52. PubMed ID: 6430210
[TBL] [Abstract][Full Text] [Related]
14. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
[TBL] [Abstract][Full Text] [Related]
16. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
17. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
[TBL] [Abstract][Full Text] [Related]
18. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of lysosomal storage diseases. Pathomorphologic and biochemical possibilities].
August CH; Holzhausen HJ; Schmidt H; Stiller D; Seidlitz G; Zschiesche M
Zentralbl Allg Pathol; 1990; 136(5):443-53. PubMed ID: 2122616
[TBL] [Abstract][Full Text] [Related]
20. [Study of the genetic heterogeneity of gangliosidoses in humans].
Akhunov VS; Aronovich EL; Krasnopol'skaia KD; Mirenburg TV
Genetika; 1989 Oct; 25(10):1861-71. PubMed ID: 2533574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]